Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients (3T Stroke-II)
Condition:   Acute Ischemic Stroke Interventions:   Drug: Alteplase;   Drug: Tenecteplase Sponsors:   Beijing Tiantan Hospital;   Jiangsu FENG HUA Biotech Pharmaceutical Co., Ltd;   The Place Pharmaceutical(Jiangsu) Co., Ltd Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 16, 2022 Category: Research Source Type: clinical trials